FDA Should Make it Easier to Hear Patients’ Voices

Patient testimony provides a critical perspective during FDA committee hearings, but the current system ignores the numerous obstacles to patient engagement. Now, a recent analysis of committee proceedings is suggesting these obstacles are leading to unwanted influence from drug companies on patient testimony. Ronnie Tepp argues the enormous importance of patient testimony, and calls on the FDA to acknowledge their responsibility to make it easier for patients’ voices to be heard.

FDA should make it easier to hear patients’ voices (Read Article)

Scroll Up